PPD, Inc. (PPDI)'s Bioanalytical Labs Certified as a Center of Bioavailability/Bioequivalence of Medicines by Brazil's National Health Surveillance Agency
3/22/2013 9:32:50 AM
WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced its bioanalytical operation has been certified by Brazil’s Agencia Nacional de Vigilancia Sanitaria (ANVISA), validating that PPD meets the agency’s stringent biopharmaceutical safety guidelines and allowing the company to conduct bioanalytical work on its clients’ compounds that will be marketed in Brazil. The governmental regulatory agency will only accept or approve products for market that have had all bioavailability/bioequivalence assay work performed at a certified facility.
comments powered by